CPI(M) attacks Kerala government over drug controversy, privatisation push

The CPI(M) has launched a sharp offensive against the Kerala government in connection with the SMA drug controversy, with party State secretary M.V. Govindan claiming that authorities are pursuing a privatisation-focused policy even within healthcare. The allegations come as the controversy continues to draw scrutiny from opposition parties seeking to hold the government accountable on public health issues. Govindan's statement reflects broader concerns within left-wing circles about the direction of state healthcare policy and resource allocation. The party has positioned the drug scandal as symptomatic of larger governance failures under the current administration. Political observers note that the CPI(M), though no longer in power in Kerala, remains a significant opposition force capable of mounting sustained pressure on contentious matters affecting public welfare and institutional integrity.